should des be the chosen one? class 22, 1st year adviser: prof. filipa almeida class 22, 1st year...
TRANSCRIPT
Bare Metal vs Drug Eluting Stents
Should DES be the chosen one?
Class 22, 1st yearAdviser: Prof. Filipa Almeida
Authors: Aguiar, A.; Alves, R.; Baptista, M.J.; Domingues, A.; Durão, N.; Máximo, J.F.; Neto, N.; Pereira, S.; Pinto, D.; Rodrigues, I.; Sousa, D.
Importance of the study
Cardiovascular diseases are the most common cause of death in Europe, being coronary disease (CD) the most frequent one1
The relevance of this study resides in the fact that there are no previous studies comparing the use of the two different types of stents in Portugal
A study based in the complications as well as success rates of bare-metal and drug-eluting stents could be significantly useful, since it would provide an evaluation on efficacy and costs.
[1] Rayner M, Allender S, Scarborough P. Cardiovascular disease in Europe. European Journal of Cardiovascular Prevention and Rehabilitation. 2009
Background
Research Question
Aims
Participants and Methods
Conclusion
Results
Coronary Disease
Occurs when the arteries that supply blood to the heart muscle (coronary arteries) become hardened and narrowed due to the build-up of cholesterol and other material, called plaque, on the inner walls of the arteries
Less blood may flow through the arteries consequently leading to the lack of oxygen in the heart muscle, causing chest pain (angina) and ultimately acute coronary syndrome (heart attack) 2
[2] Camm A, Luscher T, Serruys P. The ESC Textbook of Cardiovascular Disease.
Background
Research Question
Aims
Participants and Methods
Results
Conclusion
Percutaneous Coronary Intervention
Procedure in which a special tubing with an attached deflated balloon is threaded up to the coronary arteries 3
Balloon is inflated to widen blocked areas where blood flow to the heart muscle has been reduced or completely blocked
According to the Euro-Heart Survey 2006, in the great majority of situations (94%), PCI is combined with implantation of a stent 4
[3] American Heart Association. Cardiac Procedures and Surgeries - Nov 2010
[4] British Heart Foundation.[2008 May] Managing patients with coronary stents.
Background
Research Question
Aims
Participants and Methods
Results
Conclusion
Intracoronary Stenting (IS)
Stent: a tiny wire mesh tube that is left in the artery permanently to help maintain the artery unblocked and decrease
the chance of another blockage5
[5] Scholte op Reimer WJM, Gitt AK, Boersma E, Simoons ML (eds.). Cardiovascular Diseases in Europe.
Background
Research Question
Aims
Participants and Methods
Results
Conclusion
Intracoronary Stenting (IS)
There are two main types of stents currently in use 6:
[6] American Heart Association. Drug-eluting stents beat bare metal stents in diabetics
Background
Research Question
Aims
Participants and Methods
Results
Drug-Eluting(DES)
• Coated with a drug that fights the proliferation of cells that can block the artery
• Significantly reduce the need of repeated procedures
Bare-Metal(BMS)
• Made of stainless steel• Procedure involves
lower costs than with DES
Conclusion
Intracoronary Stenting (IS)
The relative percentages of the use of the two kinds of stents vary worldwide
Data from 2005/2006 5 , in Europe, showed a high use of DES in:◊ Switzerland 70%◊ United Kingdom 67%
On the contrary, Germany had the lowest percentage of use with only 21%
[5] Scholte op Reimer WJM, Gitt AK, Boersma E, Simoons ML (eds.). Cardiovascular Diseases in Europe.
Background
Research Question
Aims
Participants and Methods
Results
Conclusion
Research Question
What is the proportion of bare-metal and drug-eluting stents used in Portuguese patients over theperiod between 2006 and 2009 and what are the
complications associated to the use of each?
Background
Research Question
Aims
Participants and Methods
Results
Conclusion
Aims
Compare the CHD-associated complications or severity indicators, such as mortality of any cause, myocardial infarction and hospital readmission of patients admitted with acute coronary syndrome
Evaluate the rate of implantation of each of the two different types of stents - bare-metal and drug-eluting - during the period between 2006 and 2009, in angioplasties performed on the patients mentioned above
Background
Research Question
Aims
Participants and Methods
Results
Conclusion
Study Participants
The population with Coronary Heart Disease, as main diagnosis, living in the Portuguese mainland
The sample for the study is selected in a non-randomized, convenience manner from within an available clinical records database
Background
Research Question
Aims
Participants and Methods
Results
Patients with CD
Patients submitted to PCI
Intracoronary Stenting
(DES/BMS)
Conclusion
Study Participants
Inclusion Criteria
◊ All the state hospital admissions by cardiovascular disease, as main diagnosis, are selected according to the International Classification of Diseases 9th revision (ICD-9) codes
Exclusion Criteria
◊ All the admissions that do not contain the outcome information are excluded
Background
Research Question
Aims
Participants and Methods
Results
Conclusion
Study Design
Observational, retrospective and longitudinal, once the gap considered is between 2006 and 2009
The unit of observation is the population with CHD living in Portugal
Background
Research Question
Aims
Participants and Methods
Results
Conclusion
Data Collection Methods
The data was accessed from a database with records of all Portuguese State Hospitals, from 2000 to September of 2009
Available variables:
◊ Age◊ Sex ◊ Date of entry◊ Date of discharge◊ Diagnostics◊ Procedures◊ Result of admission (outcome)
Background
Research Question
Aims
Participants and Methods
Results
ICD-9 Codes Conclusion
Data Collection Methods
ICD-9 is an international standard diagnostic and procedures classification for health management purposes, epidemiological and clinical use
The codes for the cardiovascular procedures/technology are:
◊ 36.01 – 36.07 – Percutaneous coronary intervention◊ 36.07 – Drug eluting stent◊ 36.01, 36.06 – Bare metal stent
Background
Research Question
Aims
Participants and Methods
Results
Conclusion
Data Collection Methods
The ICD-9 codes for Diseases of the Circulatory system are:
IC9 - code Disease410 Acute myocardial infarction411 Other acute and subacute forms of
ischemic heart disease
412 Myocardial infarction413 Angina pectoris 414 Other forms of chronic ischemic heart
disease
Background
Research Question
Aims
Participants and Methods
Results
Conclusion
Statistical Analysis
Software used:◊ SPSS software (v. 19.0.0; SPSS Inc)
Background
Research Question
Aims
Participants and Methods
Results
Conclusion
Statistical Analysis
The period between 2000 and 2005 was eliminated because it does not have comparable data
The patients implanted with both BMS and DES were excluded, since, in those cases, it would not be possible to relate the complications to one specific type
Background
Research Question
Aims
Participants and Methods
Epected ResultsResults
DES were introduced in Portugal in 2006
Conclusion
Statistical Analysis
The variables were analysed annually
◊ Comparison BMS vs DES in each year◊ Comparison of consecutive years for each type of stent
Significance for the entire statistical analysis was accepted at p < 0,05
Background
Research Question
Aims
Participants and Methods
Epected ResultsResults
Conclusion
Statistical Analysis
Categorical Variables Analyzed:
◊ Implantation of BMS or DES ◊ Myocardial Infarction (during hospitalisation)◊ Haemorrhagic complications ◊ Readmissions * (due to Ischemic Heart Disease)◊ Mortality
Background
Research Question
Aims
Participants and Methods
Percentage and Frequency
Chi-square Test
Results
* Analysed using the number of repeated episodes, for the same patient, in the same year and hospital (due to limitations on the database)
Conclusion
Statistical Analysis
Numerical Variable Analyzed:
◊ Period of hospitalisation(measured in days; cases whose number of days of hospitalisation assumed negative values in the database were dismissed )
Background
Research Question
Aims
Participants and Methods
Median
Percentiles 5 and 95
Mann-Whitney U
Test
Results
Conclusion
Results
Background
Research Question
Aims
Participants and Methods
Results
34 272 patients
25 666 8 605
Aged between 9 and 102 years (median= 64)
Conclusion
BMS vs DES
Background
Research Question
Aims
Participants and Methods
2006* 2007* 2008* 2009*
97,5%(7994)
75,7%(6565)
57,3%(5812)
57,1%(2300)
2,5%(207)
24,3%(2102)
42,7%(4186)
42,9%(1728)
BMS vs DES
BMS DES
Graphic 1: Percentage of implantation of each type of stent per year
Results
BMS were the most frequently apllied every
year
However, they were in a remarkable decline, giving
way to DES
* p < 0,05
Conclusion
BMS vs DES
Background
Research Question
Aims
Participants and Methods
Results
The obtained results agree with Spinler et al ‘s study that also states that the use of DES have been increasing since their introduction 7
In the last two years , the percentage of DES cases seems similar
This can be related to the fact that our statistical analysis does not include cases of simultaneous implantation of both BMS and DES
[7] ] Spinler SA. Percutaneous Coronary Intervention: Assessing Coronary Vascular Risk Associated With Bare-Metal and
Drug-Eluting Stents. Am J Manag Care. March 2009; 15(2 Suppl):S42-7
Conclusion
Period of Hospitalisation
Background
Research Question
Aims
Participants and Methods
Median:◊ BMS
4 days, in all 4 years
◊ DES2 days, 20061 day, 2007 and 20083 days, 2009
The median of the period of hospitalisation was lower in the DES than in the BMS in all 4 years (2006-2009)
Comparison using the Mann-Whitney U Test demonstrated that the difference is significant (p < 0,05)
Conclusion
Results
Period of Hospitalisation
Background
Research Question
Aims
Participants and Methods
The Percentile 5 was 0 days for every year analysed, for both BMS and DES
Percentile 95:◊ BMS
15 days, 2006 and 200714 days, 2008 and 2009
◊ DES14 days, 20069 days, 2007 12 days, 200813 days, 2009
BMS presented higher values than DES for the Percentile 95
Conclusion
Results
Period of Hospitalisation
Background
Research Question
Aims
Participants and Methods
Conclusion
ResultsThe implantation of DES has high costs, but this costs can be compensated by their small period of hospitalisation
The reason why this happens could be a motive for further studies, as there are not any known references about this particular matter
DES DES
Readmissions
Background
Research Question
Aims
Participants and Methods
2006*
2007*
2008*
2009
6,2%(493)
11,5%(758)
7,3% (408)
5,9% (136)
12,1%(207)
24,5% (516)
15,2% (635)
5,8% (101)
Readmissions
DES BMS
Graphic 2: Percentage of patients readmitted per type of stent and per year
Conclusion* p < 0,05
Results
DES displayed significantly higher
results between 2006 and 2008
Comparison between consecutive years, in each type of stent:
2006-2007
2007-20082008-2009
Readmissions
In a global vision, the percentage of readmissions decreases over the years, independently of the type of stent
Background
Research Question
Aims
Participants and Methods
Conclusion
Results
Why?
Improvement of PCI techniques
Evolution of post-surgical treatments
Haemorrhagic Complications
Background
Research Question
Aims
Participants and Methods
2006 2007 2008 2009
0,2%(18)
0,3%(19)
0,3%(18)(11)
0,4%(10)
0,0%(0)
0,2%(4)
0,8%(14)
Haemorrhagic Complications
BMS DES
Graphic 3: Percentage of patients who had haemorrhagic complications during hospitalization per type of stent and per year
Conclusion
Results
Higher percentage for BMS in the first 2 years
Same percentage for both in 2008
Higher percentage for DES in 2009
The Differences are not statistically significant
It can not be concluded that there is a link between the
type of stent implanted and the development of
haemorrhagic complications
Myocardial Infarction
Background
Research Question
Aims
Participants and Methods
2006*
2007*
2008*
2009
5,0%(403)
4,8%(312)
4,8%(289)
4,9%(113)
1,4% (3)
3,0% (63)
3,2%(133)
5,8%(101)
Myocardial Infarction
DES BMS
Graphic 4: Percentage of patients who had myocardial infarction during hospitalization per type of stent and per year
Conclusion
* p < 0,05
Results
BMS cases showed a higher incidence between
2006 and 2008
In 2009, the incidence increased in DES cases, being significant when compared with 2008
(p=0,003)
Myocardial Infarction
Background
Research Question
Aims
Participants and Methods
Conclusion
Results
The significant augment of myocardial infarction for DES in 2009 could be explained by the reduction of the sample size, comparing with the two previous years
Over-increased the percentages of both myocardial infarction and haemorrhagic complications for DES
Mortality
Background
Research Question
Aims
Participants and Methods
Results
2006 2007* 2008* 2009*
1,8% (143)
2,1% (140) 2,1% (119)2,2% (50)
1,9% (4)
0,5% (11)0,6% (26)
1,0% (18)
Mortality
BMS DES
Graphic 5: Percentage of patients deceased per type of stent and per year
Discussion
* p < 0,05
Mortality is significantly higher in BMS cases, with the exception of 2006
The difference in 2006 is not statistically
significant
Comparison of consecutive years, in each type of stent:
DES 2006-2007
Mortality
Background
Research Question
Aims
Participants and Methods
Results
Discussion
DES has a lower mortality rate than BMS
This result is supported by various works 8,9,10 and could be related to a long-lasting antiplatelet therapy associated to DES 9
The relevant decrease between 2006 and 2007 in DES mortality could be related to its recent introduction in Portugal , resulting in a very small sample on the first year
[8] Mauri L, Silbaugh TS, Wolf RE, et al. Long-Term Clinical Outcomes Following Drug-eluting and Bare Metal Stenting in Massachusetts. Circulation. 2008;118(18):1817-27.[9] Tamburino C, Salvo M, Capodanno D, et al. Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry. European Heart Journal. 2009; 30:1171-1179[10] Marroquin O, Selzer F, Mulukutla S, et al. A Comparison of Bare-Metal and Drug-Eluting Stents for Off-Label Indications. N Engl J Med. 2008; 358:342-352
The small augment in the mortality rate in 2009, though not significant, can be related to the similar increase in myocardial infarction for both types of stent
Limitations
Background
Research Question
Aims
Participants and Methods
Results
The non-inclusion of patients admitted and treated in private institutions/hospitals as well as in autonomous regions (Madeira and Azores)
Errors in the database (negative values for period of hospitalisation)
Exclusion of cases of simultaneous implantation of both BMS and DES
Conclusion
Limitations
Background
Research Question
Aims
Participants and Methods
Results
Readmissions are only considered for the same hospital, and in the same year(due to limitations on the database)
Co-morbidities that could act as confusion bias were not taken into account for any of the analysed variables (This is a pertinent limitation of this study, which may affect all available outcomes, with particular relevance for mortality 9 )
Conclusion
[9] Tamburino C, Salvo M, Capodanno D, et al. Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry. European Heart Journal. 2009; 30:1171-1179
Final Conclusions
Background
Research Question
Aims
Participants and Methods
Results
BMS have been the most frequently applied stents in Portugal
The use of DES has been rapidly increasing since 2006
DES show a lower percentage of mortality and myocardial infarction, and a shorter period of hospitalisation
DES show a higher percentage of readmissions
Conclusion
Final Conclusions
Background
Research Question
Aims
Participants and Methods
Results
Conclusion
No link was found between the development of haemorrhagic complications and the type of stent implanted
All in all, even though in a short-term analysis it can be concluded that DES are more beneficial than BMS, despite the higher costs, presently, we cannot make a long-term analysis to further study our economic objective